Neuron-binding antibody responses are associated with Black ethnicity in multiple sclerosis during natalizumab treatment is a research paper published in Brain Communications (2023). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Center for Advancing Translational Sciences Weill Cornell Medicine Fellowship
Grant: TL1TR002386-01
National Institute of Allergy and Infectious Diseases
Grant: 1R21 AI144819-01A1
Determining Enhanced Inflammatory B cell Function in African Americans with MS
National Institute of Neurological Disorders and Stroke
Grant: R01 NS123398-01
National Institute of Neurological Disorders and Stroke
Grant: K22 NS123508-01
NINDS NIH HHS
Grant: R01 NS102417
NCATS NIH HHS
Grant: TL1 TR002386
NINDS NIH HHS
Grant: K22 NS123508
NINDS NIH HHS
Grant: R01 NS123398
NCI NIH HHS
Grant: P30 CA142543
NIAID NIH HHS
Grant: R21 AI144819
NIH HHS
Grant: S10 OD028630
National Institutes of Health
Grant: 2TL1TR002386-06
J. NRSA Training Core
National Institutes of Health
Grant: 5R01NS123398-02
Immunology of advancing disease among minorities with Multiple Sclerosis
National Institutes of Health
Grant: 3P30CA142543-12S1
Multidimensional single-cell approach probing HIV-1 integration association with non-AIDS defining cancers (Biospecimens/Biocohort)
National Institutes of Health
Grant: 1S10OD028630-01
Spinning Disk Confocal for UT Southwestern
National Institutes of Health
Grant: 1K22NS123508-01
Ethnicity-associated, differential CNS demyelinating autoimmune disease severity: reconciling identity, ancestry and neurotoxic antibody response
FWCI
0.70
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords